comprehensive -WSS

comprehensive

author：fashion 2025-09-06 03:28:12 - browse：6626

Silver Apple Watch — Charles Rex Arbogast/AP

Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders.

Rune in 2022 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication. The app also collects sleep, activity, and medication data and can serve as a focal point for education and care management for people with Parkinson’s. The app can help users make day-to-day decisions about lifestyle and medication and help inform care decisions by providers. Rune also works with drug companies developing treatments for the disease.

Rune Labs CEO Brian Pepin told STAT the company will use the funds to push the adoption of its technology among health plans that can use it to manage care for their members with Parkinson’s disease. The company last year finalized a deal with “a large California health system” and now hopes to go out and sell to more organizations that have Medicare Advantage plans or other at-risk populations they serve. This requires an investment in business development staff and people to manage those relationships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： California Joshua trees severely burned in massive wildfire

WSS

Scientists find bacteria from stomach of ancient iceman

Telehealth for opioid use disorder is lifesaving

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

Food makers tried to stack nutrition panel with preferred experts

FDA panel endorses Alnylam’s heart drug — after picking it apart

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

knowledge

comprehensive

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Russian court extends detention of American musician

How one medical school became remarkably diverse

Acelyrin, a rare IPO success, stumbles in its first big test

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Climate activists disrupt London Pride march to protest corporate sponsorship

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medical mystery: When an infection after surgery isn’t what it seems

Malaria cases in Florida and Texas: Here’s what you need to know

Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs

hotspot

'Cuddling' is just what the doctor ordered for a 200

Eat, drink, but be wary — 4 foods that interact with medications

New weight loss drugs vying to be the next Wegovy or Mounjaro

California Joshua trees severely burned in massive wildfire

IRA could hurt research into orphan drugs for rare diseases

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

focus

focus

entertainment

focus